These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19483056)

  • 1. Severe hepatitis associated with sitaxentan and response to glucocorticoid therapy.
    Hoeper MM; Olsson KM; Schneider A; Golpon H
    Eur Respir J; 2009 Jun; 33(6):1518-9. PubMed ID: 19483056
    [No Abstract]   [Full Text] [Related]  

  • 2. Sitaxsentan-induced acute severe hepatitis treated with glucocorticoid therapy.
    Chin M; Levy RD; Yoshida EM; Byrne MF
    Can Respir J; 2012; 19(1):e1-2. PubMed ID: 22332138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sitaxentan-induced hepatic failure in two patients with pulmonary arterial hypertension.
    Lavelle A; Sugrue R; Lawler G; Mulligan N; Kelleher B; Murphy DM; Gaine SP
    Eur Respir J; 2009 Sep; 34(3):770-1. PubMed ID: 19720812
    [No Abstract]   [Full Text] [Related]  

  • 4. Liver toxicity of sitaxentan in pulmonary arterial hypertension.
    Galiè N; Hoeper MM; Simon J; Gibbs R; Simonneau G;
    Eur Heart J; 2011 Feb; 32(4):386-7. PubMed ID: 21416695
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
    Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
    Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver toxicity: the Achilles' heel of endothelin receptor antagonist therapy?
    Hoeper MM
    Eur Respir J; 2009 Sep; 34(3):529-30. PubMed ID: 19720805
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver toxicity of sitaxentan in pulmonary arterial hypertension.
    Galiè N; Hoeper MM; Gibbs JS; Simonneau G
    Eur Respir J; 2011 Feb; 37(2):475-6. PubMed ID: 21282816
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatotoxicity in patients treated with endothelin receptor antagonists: systematic review and meta-analysis of randomized clinical trials].
    Macías Saint-Gerons D; de la Fuente Honrubia C; Montero Corominas D; Catalá-López F
    Med Clin (Barc); 2014 Apr; 142(8):333-42. PubMed ID: 23540381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sitaxentan: new drug. Pulmonary hypertension: better to continue to use bosentan.
    Prescrire Int; 2008 Jun; 17(95):108. PubMed ID: 18630348
    [No Abstract]   [Full Text] [Related]  

  • 10. Successful treatment of portopulmonary hypertension with the selective endothelin receptor antagonist Sitaxentan.
    Kähler CM; Graziadei I; Vogelsinger H; Desole S; Cima K; Vogel W
    Wien Klin Wochenschr; 2011 Apr; 123(7-8):248-52. PubMed ID: 21451953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Achilles heel of endothelin receptor therapy for pulmonary arterial hypertension.
    Corris PA; Langleben D
    Eur Respir J; 2010 Feb; 35(2):460-1; author reply 461. PubMed ID: 20123858
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].
    Montani D; Humbert M
    Rev Mal Respir; 2010 Feb; 27(2):103-5. PubMed ID: 20206056
    [No Abstract]   [Full Text] [Related]  

  • 13. Leflunomide-induced acute hepatitis.
    Sevilla-Mantilla C; Ortega L; Agúndez JA; Fernández-Gutiérrez B; Ladero JM; Díaz-Rubio M
    Dig Liver Dis; 2004 Jan; 36(1):82-4. PubMed ID: 14971821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension.
    Beghetti M; Galiè N
    J Am Coll Cardiol; 2009 Mar; 53(9):733-40. PubMed ID: 19245962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin receptor antagonists-induced hepatotoxicity.
    Macías Saint-Gerons D; de la Fuente Honrubia C; Montero D; Catalá-López F
    Intern Med J; 2013 May; 43(5):609-10. PubMed ID: 23668280
    [No Abstract]   [Full Text] [Related]  

  • 16. Endothelin receptor antagonists and scleroderma related digital ulcers.
    Lee WY; Faruqi S; Morice AH
    Acta Reumatol Port; 2013; 38(1):58-9. PubMed ID: 24131915
    [No Abstract]   [Full Text] [Related]  

  • 17. Sitaxsentan: a novel endothelin-A receptor antagonist for pulmonary arterial hypertension.
    Widlitz AC; Barst RJ; Horn EM
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):985-91. PubMed ID: 16292989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Updated treatment of primary pulmonary hypertension -- the role of endothelin receptor antagonists].
    Callejas Rubio JL; Ortego Centeno N; Navarro Pelayo F; Vallejo Rodríguez I
    Farm Hosp; 2004; 28(4):294-5. PubMed ID: 15369441
    [No Abstract]   [Full Text] [Related]  

  • 19. [Thiophene-induced hepatitis: a new case].
    Hastier P; Bianchi D; Kuhdorf H; Arpurt JP; Chichmanian R; Saint-Paul MC; Delmont J
    Gastroenterol Clin Biol; 1993; 17(8-9):613-4. PubMed ID: 8253330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Endothelin-receptor antagonists in therapy of pulmonary arterial hypertension].
    Ghofrani HA
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S177-8. PubMed ID: 19718611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.